$ALNY ALNYLAM PHARMACEUTICALS, INC. Insider Trading Week 20/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ALNYLAM PHARMACEUTICALS, INC. in week 20/2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 15.91 | 15,000 | 238,650 | 0 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 14.74 | 10,000 | 147,400 | 0 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Option Exercise | M | 7.08 | 10,000 | 70,800 | 0 | |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 56.19 | 2,800 | 157,340 | 0 | 2.8 K to 0 (-100.00 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 55.47 | 6,908 | 383,176 | 2,800 | 9.7 K to 2.8 K (-71.16 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 54.21 | 2,500 | 135,536 | 9,708 | 12.2 K to 9.7 K (-20.48 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Sell | S | 52.95 | 22,792 | 1,206,928 | 12,208 | 35 K to 12.2 K (-65.12 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 15.91 | 15,000 | 238,650 | 35,000 | 20 K to 35 K (+75.00 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 14.74 | 10,000 | 147,400 | 20,000 | 10 K to 20 K (+100.00 %) |
May 23 2014 | ALNY | ALNYLAM PHARMACEUT ... | CLARKE JOHN K | Director | Buy | M | 7.08 | 10,000 | 70,800 | 10,000 | 0 to 10 K |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 9.14 | 11,000 | 100,540 | 16,589 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Option Exercise | M | 7.10 | 2,500 | 17,750 | 17,500 | |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 58.01 | 10,900 | 632,310 | 3,905 | 14.8 K to 3.9 K (-73.62 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Sell | S | 57.07 | 2,600 | 148,374 | 14,805 | 17.4 K to 14.8 K (-14.94 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 9.14 | 11,000 | 100,540 | 17,405 | 6.4 K to 17.4 K (+171.74 %) |
May 21 2014 | ALNY | ALNYLAM PHARMACEUT ... | Reid Laurence | SVP, Chief Business ... | Buy | M | 7.10 | 2,500 | 17,750 | 6,405 | 3.9 K to 6.4 K (+64.02 %) |